Related Experiment Video
Updated: Aug 6, 2025
08:44
Assembly and Characterization of Polyelectrolyte Complex Micelles
Published on: March 2, 2020
10.9K
DNA-Polyelectrolyte Composite Responsive Microparticles for Versatile Chemotherapeutics Cleaning
Chong Wang1, Jiali Wang1, Zhuohao Zhang1
1Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, and the Shanghai Key Laboratory of Medical Epigenetics, the International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology) Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Research (Washington, D.C.)
|March 20, 2023
Summary
New DNA-polyelectrolyte microparticles can clean excess chemotherapy drugs from blood. This blood purification method may help reduce drug toxicity while maintaining treatment effectiveness.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Chemical Engineering
Background:
- Drug therapy is essential but faces a dosage-toxicity trade-off.
- Blood purification offers a way to manage drug levels and toxicity.
- Targeting DNA is a key mechanism for chemotherapy drugs.
Purpose of the Study:
- To develop DNA-polyelectrolyte composite microparticles for effective chemotherapy drug removal.
- To enhance drug adsorption using microparticle porosity and photothermal responsiveness.
- To integrate these microparticles into a microfluidic chip for validated blood purification.
Main Methods:
- Fabrication of DNA-polyelectrolyte composite microparticles.
- Incorporation of porous structure and photothermal responsiveness into microparticles.
- Integration of microparticles into a herringbone-structured microfluidic chip.
- On-chip validation of fluid mixing and drug cleaning efficiency.
Main Results:
- DNA presence in microparticles facilitated adsorption of common chemotherapy drugs.
- Porous structure and photothermal response enhanced drug adsorption capacity.
- The microfluidic platform demonstrated efficient drug cleaning.
- The system validated improved fluid mixing and drug removal.
Conclusions:
- DNA-polyelectrolyte composite microparticles show significant potential for chemotherapy drug capture.
- The microparticle-integrated microfluidic platform offers a promising approach for blood purification.
- This technology could help mitigate the dosage-toxicity issues in chemotherapy treatments.
